Our Medicines

ViiV Healthcare remains committed to developing new medicines and investing in innovations that will improve patient’s treatment success and quality of life. We hope you find the ViiV Exchange a valuable resource to learn more about our current medicines, clinical data and prescribing information.

TRIUMEQ

TRIUMEQ does not cure HIV infection: it reduces the amount of the virus in the patient's body, and keeps it at a low level. TRIUMEQ also increases the CD4 cell count in their blood. CD4 cells are a type of white blood cell that are important in helping our bodies to fight infection.

TIVICAY

TIVICAY does not cure HIV infection; it reduces the amount of virus in the patient's body, and keeps it at a low level. TIVICAY also increases the CD4 cell count in their blood. CD4 cells are a type of white blood cell that are important in helping our bodies to fight infection.

 

TIVICAY is used, in combination with other anti-retroviral medicines (combination therapy), to treat HIV infection in adults and children over 12 years old. 

Other Medicines

For full Product Information and Consumer Medicine Information for ViiV Healthcare’s other medicines, please visit  
https://www.viivhealthcare.com.au/our-medicines/

 

For full Product Information and Consumer Medicine Information for ViiV Healthcare’s other medicines, please visit 

www.viivhealthcare.com.au
Conference Conference Conference

Speak to a ViiV Healthcare representative

If you are a healthcare professional, you may request to speak directly with a medical advisor or product specialist. The general public are advised to consult their healthcare provider.

Contact us

Date of Preparation: July 2017 | AUS/HIV/0057/17